$SSY
SUNLINK HEALTH SYSTEMS INC

2013 Q4 Form 10-Q Financial Statement

#000119312514055123 Filed on February 14, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2012 Q4
Revenue $26.11M $30.39M
YoY Change -14.07% -3.24%
Cost Of Revenue $1.350M $1.896M
YoY Change -28.8% 2.05%
Gross Profit $24.76M $28.49M
YoY Change -13.09% -3.57%
Gross Profit Margin 94.83% 93.76%
Selling, General & Admin $14.53M $18.35M
YoY Change -20.82% 3.44%
% of Gross Profit 58.68% 64.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $763.0K $989.0K
YoY Change -22.85% -11.7%
% of Gross Profit 3.08% 3.47%
Operating Expenses $17.10M $22.29M
YoY Change -23.28% 0.09%
Operating Profit $291.0K -$974.0K
YoY Change -129.88% -8.03%
Interest Expense $238.0K $647.0K
YoY Change -63.21% -37.25%
% of Operating Profit 81.79%
Other Income/Expense, Net $1.298M $1.024M
YoY Change 26.76% 67.05%
Pretax Income $53.00K -$1.621M
YoY Change -103.27% -22.44%
Income Tax -$297.0K -$226.0K
% Of Pretax Income -560.38%
Net Earnings $227.0K $3.935M
YoY Change -94.23% -520.86%
Net Earnings / Revenue 0.87% 12.95%
Basic Earnings Per Share $0.02 $0.42
Diluted Earnings Per Share $0.02 $0.42
COMMON SHARES
Basic Shares Outstanding 9.443M shares 9.446M shares
Diluted Shares Outstanding 9.478M shares 9.446M shares

Balance Sheet

Concept 2013 Q4 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.600M $8.500M
YoY Change -45.88% 1600.0%
Cash & Equivalents $4.561M $7.733M
Short-Term Investments
Other Short-Term Assets $10.20M $10.60M
YoY Change -3.77% 4.95%
Inventory $3.925M $3.922M
Prepaid Expenses
Receivables $1.858M $14.23M
Other Receivables $400.0K $700.0K
Total Short-Term Assets $29.90M $37.86M
YoY Change -21.01% 14.03%
LONG-TERM ASSETS
Property, Plant & Equipment $29.77M $30.39M
YoY Change -2.04% -4.74%
Goodwill $461.0K $461.0K
YoY Change 0.0%
Intangibles $3.103M $3.248M
YoY Change -4.46%
Long-Term Investments
YoY Change
Other Assets $1.495M $1.735M
YoY Change -13.83% -84.23%
Total Long-Term Assets $38.62M $39.85M
YoY Change -3.07% -16.46%
TOTAL ASSETS
Total Short-Term Assets $29.90M $37.86M
Total Long-Term Assets $38.62M $39.85M
Total Assets $68.52M $77.70M
YoY Change -11.81% -3.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.817M $8.402M
YoY Change -30.77% 6.35%
Accrued Expenses $5.800M $6.900M
YoY Change -15.94% -6.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $865.0K $9.488M
YoY Change -90.88% 351.81%
Total Short-Term Liabilities $16.12M $33.37M
YoY Change -51.69% 2.37%
LONG-TERM LIABILITIES
Long-Term Debt $16.94M $6.435M
YoY Change 163.17% -69.21%
Other Long-Term Liabilities $799.0K $724.0K
YoY Change 10.36% -84.6%
Total Long-Term Liabilities $19.56M $12.49M
YoY Change 56.65% -51.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.12M $33.37M
Total Long-Term Liabilities $19.56M $12.49M
Total Liabilities $35.68M $45.86M
YoY Change -22.19% -21.21%
SHAREHOLDERS EQUITY
Retained Earnings $15.10M $14.05M
YoY Change 7.44%
Common Stock $4.722M $4.725M
YoY Change -0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.84M $31.80M
YoY Change
Total Liabilities & Shareholders Equity $68.52M $77.70M
YoY Change -11.81% -3.95%

Cashflow Statement

Concept 2013 Q4 2012 Q4
OPERATING ACTIVITIES
Net Income $227.0K $3.935M
YoY Change -94.23% -520.86%
Depreciation, Depletion And Amortization $763.0K $989.0K
YoY Change -22.85% -11.7%
Cash From Operating Activities $1.160M $2.710M
YoY Change -57.2% 721.21%
INVESTING ACTIVITIES
Capital Expenditures $406.0K $417.0K
YoY Change -2.64% -331.67%
Acquisitions
YoY Change
Other Investing Activities -$80.00K $8.310M
YoY Change -100.96% -11971.43%
Cash From Investing Activities -$480.0K $7.880M
YoY Change -106.09% -3252.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -310.0K -3.370M
YoY Change -90.8% -11333.33%
NET CHANGE
Cash From Operating Activities 1.160M 2.710M
Cash From Investing Activities -480.0K 7.880M
Cash From Financing Activities -310.0K -3.370M
Net Change In Cash 370.0K 7.220M
YoY Change -94.88% 6463.64%
FREE CASH FLOW
Cash From Operating Activities $1.160M $2.710M
Capital Expenditures $406.0K $417.0K
Free Cash Flow $754.0K $2.293M
YoY Change -67.12% 349.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q4 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
212000
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16935000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35923000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13427000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5817000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16123000
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9443408 shares
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7733000
CY2012Q4 us-gaap Assets Net
AssetsNet
77634000
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7799000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9446000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9446000 shares
CY2013Q4 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2013Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2013Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
24.74 acre
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-406000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3905000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
799000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
32843000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7239000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15100000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3630000
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
17800000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
4722000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68524000
CY2013Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
49000
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
19558000
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1906000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
865000
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
10839000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
29902000
CY2013Q4 us-gaap Goodwill
Goodwill
461000
CY2013Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
8856000
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
185000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3103000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1495000
CY2013Q2 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2013Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q2 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
216000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3797000
CY2013Q4 us-gaap Assets
Assets
68524000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4561000
CY2013Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
18078000
CY2013Q4 us-gaap Escrow Deposit
EscrowDeposit
0
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1858000
CY2013Q4 us-gaap Inventory Net
InventoryNet
3925000
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
8326000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65689000
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2348000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3825000
CY2013Q4 us-gaap Assets Net
AssetsNet
68524000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4529000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29766000
CY2013Q4 ssy Amount Of Installment
AmountOfInstallment
150000
CY2013Q4 ssy Incentive Reimbursement Assets Current
IncentiveReimbursementAssetsCurrent
180000
CY2013Q4 ssy Due To Third Party Payors
DueToThirdPartyPayors
0
CY2013Q4 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
1824000
CY2011Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
37000
CY2012Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
19000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2057000
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9447000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9447000 shares
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8728000
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34266000
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13396000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5474000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
22246000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-406000
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
229000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4121000
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
825000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
33743000
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7761000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16031000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1136000
CY2013Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
18270000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
4722000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68003000
CY2013Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
90000
CY2013Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12014000
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1417000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
9542000
CY2013Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
12356000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
28093000
CY2013Q2 us-gaap Goodwill
Goodwill
461000
CY2013Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
9336000
CY2013Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1769000
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3175000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1587000
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4113000
CY2013Q2 us-gaap Assets
Assets
68003000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2497000
CY2013Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
20117000
CY2013Q2 us-gaap Escrow Deposit
EscrowDeposit
160000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2013Q2 us-gaap Inventory Net
InventoryNet
3798000
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
64840000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3505000
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4008000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30574000
CY2013Q2 ssy Incentive Reimbursement Assets Current
IncentiveReimbursementAssetsCurrent
0
CY2013Q2 ssy Due To Third Party Payors
DueToThirdPartyPayors
556000
CY2013Q2 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
2461000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9446000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
120000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.32
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9446000 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.59
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.59
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.32
us-gaap Revenues
Revenues
59557000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2511000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4671000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-308000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
17007000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
5528000
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
5712000
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
9553000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-3465000
us-gaap Interest Paid
InterestPaid
1208000
us-gaap Net Income Loss
NetIncomeLoss
2511000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
573000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3017000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
20000
us-gaap Sales Revenue Net
SalesRevenueNet
53540000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1135000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
753000
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
525000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
789000
us-gaap Other Expenses
OtherExpenses
1024000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10795000
us-gaap Cost Of Services
CostOfServices
3852000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
10766000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8081000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
257000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5676000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
68000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
288000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1004000
us-gaap Interest Expense
InterestExpense
1206000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
4598000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
34000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16351000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
6017000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1973000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-5931000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
12143000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
70000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
54000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
52000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
26607000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1366000
us-gaap Supplies Expense
SuppliesExpense
4700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1654000
ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
51000
ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
9513000
ssy Payments To Acquire Property Plant And Equipment Discontinued Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations
41000
ssy Net Revenue Related To Settlements And Filings Of Prior Year Reports
NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports
176000
dei Entity Registrant Name
EntityRegistrantName
SUNLINK HEALTH SYSTEMS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
us-gaap Line Of Credit Facility Initiation Date1
LineOfCreditFacilityInitiationDate1
2008-04-23
dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000096793
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9446000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>Note 2. &#x2013; Business Operations</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <u>Business Operations</u></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> SunLink Health Systems, Inc., through subsidiaries, owns businesses which are providers of healthcare services in certain markets in the United States. SunLink&#x2019;s business is composed of the ownership of two business segments:</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The Healthcare Facilities Segment is composed of three operational areas:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Four community hospital subsidiaries in three states with a total of 232 licensed beds;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Two nursing homes with a total of 166 licensed beds, each of which is located adjacent to, or in close proximity with a corresponding SunLink community hospital; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">A healthcare facility which is currently being repurposed for a multi-tenant medical park.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The Specialty Pharmacy Segment is composed of four operational areas:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Retail pharmacy products and services, all of which are conducted in rural markets;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Institutional pharmacy services;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Specialty pharmacy services; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Durable medical equipment.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> SunLink subsidiaries have conducted the healthcare facilities business since 2001 and the specialty pharmacy business since April 2008. The Specialty Pharmacy Segment currently is operated through Carmichael&#x2019;s Cashway Pharmacy, Inc. (&#x201C;Carmichael&#x201D;), a subsidiary of SunLink ScriptsRx, LLC subsidiary, and is composed of a specialty pharmacy business acquired in April 2008 with four service lines.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> SunLink&#x2019;s Board and management have determined to focus the Company&#x2019;s strategic investments on enhancing the existing hospital portfolio, and seeking to improve the operations of its Specialty Pharmacy Segment. The Company believes its four remaining hospital facilities are presently underperforming and currently is evaluating the possible sale of one or more of these hospital facilities. There is no assurance any sale will occur or that, if a sale occurs, it will be at a price that results in a gain or net proceeds after transaction costs, taxes and outstanding debt. The Company expects to use a portion of the net proceeds, if any, from future asset sales to fund its working capital needs.</p> <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px 'Times New Roman'; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> On February&#xA0;5, 2013, the Company announced the commencement of a tender offer to purchase at the price of $1.50 per share in cash all of its common shares held by holders of 99 or fewer shares (&#x201C;odd lots&#x201D;) who owned such shares as of the close of business on January&#xA0;31, 2013 (&#x201C;Odd Lot Tender Offer&#x201D;). In addition to the $1.50 per share price, the Company offered each eligible tendering holder a bonus of one hundred dollars ($100) upon completion of the Odd Lot Tender Offer for the tender of all shares&#xA0;beneficially owned by such holder which were received&#xA0;and not withdrawn prior to the date of expiration of the Odd Lot Tender Offer, which was March&#xA0;26, 2013. In accordance with the terms and conditions of the Offer, SunLink accepted for purchase a total of 2,631 common shares of SunLink tendered by 68 holders pursuant to the Offer. As a result of the completion of the Offer, immediately following payment for the tendered shares, the Company has approximately 9,443,000 common shares issued and outstanding and held by approximately 480 stockholders of record. The shares repurchased were retired immediately. The aggregate cash cost of the Odd Lot Tender Offer was $195 and was recorded in equity. Included in the cash cost are purchase price for the odd lot shares of $4, aggregate bonus payments of $7 and fees and expenses of $184.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The primary purpose of the Odd Lot Tender Offer was to reduce the number of holders of record of the Company&#x2019;s common shares in order to permit the Company to deregister the common shares with the SEC. The Company&#x2019;s Board and management each believes that deregistering the Company&#x2019;s common shares will result in significant cost savings. Since the Offer failed to accomplish the objective of reducing the number of record holders to fewer than 300, SunLink anticipates that it will take further actions to reduce the number of holders of record of the Company&#x2019;s common shares in order to permit the Company to deregister the common shares with the SEC. As previously disclosed in the Company&#x2019;s offer to purchase, the Board will likely consider other alternatives to achieve that result, including a further tender offer, a reverse stock split or cash out merger (in which a new corporation is formed to merge with the Company and holders of a limited number of Company shares are cashed out), so long as the Board continues to believe that deregistration remains in the Company&#x2019;s best interests.</p> </div>
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2013-01-01
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3545000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.13
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9446000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.03
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.13
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
14000
us-gaap Interest Paid
InterestPaid
575000
us-gaap Net Income Loss
NetIncomeLoss
-931000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
391000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1187000
us-gaap Sales Revenue Net
SalesRevenueNet
52642000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
851000
us-gaap Pension Contributions
PensionContributions
54000
us-gaap Revenues
Revenues
58259000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-931000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1671000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1629000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
470000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
256000
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-1052000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
160000
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
319000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Other Expenses
OtherExpenses
1298000
us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
9000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-470000
us-gaap Cost Of Services
CostOfServices
3758000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
6234000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
10760000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7405000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
95000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2064000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
79000
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1621000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
17000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
919000
us-gaap Interest Expense
InterestExpense
619000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
135000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
30000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1011000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
5617000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1805000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
218000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
63000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
25755000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
467000
us-gaap Supplies Expense
SuppliesExpense
4495000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-484000
ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
67000
ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
509000
ssy Payments To Acquire Property Plant And Equipment Discontinued Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations
0
ssy Net Revenue Related To Settlements And Filings Of Prior Year Reports
NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports
456000
ssy Number Of Physicians Under Guarantee Agreements
NumberOfPhysiciansUnderGuaranteeAgreements
1 Physician
ssy Number Of Years Required For Maintaining Practice
NumberOfYearsRequiredForMaintainingPractice
P3Y
CY2009 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2009
CY2010 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2010
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
218000
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
8000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
18000
CY2011 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2011
ssy Number Of Law Firms Related To Entities
NumberOfLawFirmsRelatedToEntities
2 Law_Firm
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2012Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9446000 shares
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2012Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.15
CY2012Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9446000 shares
CY2012Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.56
CY2012Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.56
CY2012Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.15
CY2012Q4 us-gaap Revenues
Revenues
30385000
CY2012Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3935000
CY2012Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
5330000
CY2012Q4 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
8362000
CY2012Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-974000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
3935000
CY2012Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
196000
CY2012Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1395000
CY2012Q4 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
10000
CY2012Q4 us-gaap Sales Revenue Net
SalesRevenueNet
27850000
CY2012Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
417000
CY2012Q4 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
312000
CY2012Q4 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2012Q4 us-gaap Other Expenses
OtherExpenses
1024000
CY2012Q4 us-gaap Cost Of Services
CostOfServices
1896000
CY2012Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6529000
CY2012Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3976000
CY2012Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
177000
CY2012Q4 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
34000
CY2012Q4 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
419000
CY2012Q4 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
458000
CY2012Q4 us-gaap Interest Expense
InterestExpense
647000
CY2012Q4 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
3228000
CY2012Q4 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
17000
CY2012Q4 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
2535000
CY2012Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
989000
CY2012Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000
CY2012Q4 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
27000
CY2012Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24000
CY2012Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
13386000
CY2012Q4 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
193000
CY2012Q4 us-gaap Supplies Expense
SuppliesExpense
2437000
CY2012Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-226000
CY2012Q4 ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
20000
CY2012Q4 ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
4684000
CY2012Q4 ssy Net Revenue Related To Settlements And Filings Of Prior Year Reports
NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports
27000
CY2013Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
789000
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9447000 shares
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2013Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.00
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9447000 shares
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.03
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.03
CY2013Q4 us-gaap Interest Expense
InterestExpense
307000
CY2013Q4 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
129000
CY2013Q4 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
15000
CY2013Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.00
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2941000
CY2013Q4 us-gaap Pension Contributions
PensionContributions
54000
CY2013Q4 us-gaap Revenues
Revenues
29963000
CY2013Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
227000
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-495000
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
240000
CY2013Q4 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0
CY2013Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-188000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
227000
CY2013Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
369000
CY2013Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-13000
CY2013Q4 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
7000
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
27064000
CY2013Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
478000
CY2013Q4 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
159000
CY2013Q4 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2013Q4 us-gaap Other Expenses
OtherExpenses
1298000
CY2013Q4 us-gaap Cost Of Services
CostOfServices
1907000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3501000
CY2013Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6485000
CY2013Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3694000
CY2013Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
42000
CY2013Q4 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
40000
CY2013Q4 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
31000
CY2013Q4 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
458000
CY2013Q4 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
2899000
CY2013Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
898000
CY2013Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000
CY2013Q4 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
32000
CY2013Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15000
CY2013Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12768000
CY2013Q4 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
513000
CY2013Q4 us-gaap Supplies Expense
SuppliesExpense
2298000
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-482000
CY2013Q4 ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
33000
CY2013Q4 ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
420000
CY2013Q4 ssy Net Revenue Related To Settlements And Filings Of Prior Year Reports
NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports
252000

Files In Submission

Name View Source Status
0001193125-14-055123-index-headers.html Edgar Link pending
0001193125-14-055123-index.html Edgar Link pending
0001193125-14-055123.txt Edgar Link pending
0001193125-14-055123-xbrl.zip Edgar Link pending
d634142d10q.htm Edgar Link pending
d634142dex311.htm Edgar Link pending
d634142dex312.htm Edgar Link pending
d634142dex321.htm Edgar Link pending
d634142dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssy-20131231.xml Edgar Link completed
ssy-20131231.xsd Edgar Link pending
ssy-20131231_cal.xml Edgar Link unprocessable
ssy-20131231_def.xml Edgar Link unprocessable
ssy-20131231_lab.xml Edgar Link unprocessable
ssy-20131231_pre.xml Edgar Link unprocessable